Summary
Immune thrombocytopenia (ІTP) is one of the most common causes of clinically overt hemorrhage. Despite the made the progress in recent years in clarifying pathogenesis of the disease unlock mechanisms , the exact still remain unclear.
correlat The aim of the study was to e the the oxidative stress markers and severity of immune thrombocytopenia in adults and to investigate their predictive value of ing ITP into transform the acute form of chronic ІT . a total of 58 14 patients P We studied subjects ( with newly diagnosed ІT , 13 patients with chronic form P of ІTR 31 human , and controls). The plasma levels of pantetheinase v -and were ( anin 1) lipid hydroperoxides measured using commercial assay kits. We found that the form of the disease was not significantly related to the plasma v -(p=0.120) 
Introduction
Immune thrombocytopenia (ІT ) is among the most P common causes of hemorrhagic manifestations in clinical practice and serve as a model of could autoimmune disease. The primary ІTP is an immuneconditioned disorder characterized by isolated thrombocytopenia with platelet count below 100 x a 10 /L, and the absence of other causes or disorders 9 , which can be associated with thrombocytopenia .
[1] Despite progress in recent years in the made clarifying pathogenesis of the disease the , the exact unlock mechanisms and mechanism the of onset of certain immunity disorders still remain unclear. Moreover, the clinical manifestations of the disease are highly variable, and today is no specific there diagnostic marker or etiology specific therapy. 
J Biomed Clin Res

Patients and Methods
Subjects Tested
The present study conducted from October was 201 to 201 comprised patients, of 5 May 6 and 27 whom 14 with newly diagnosed were subjects form of ІT 13 -with chronic form of ІTR P and . Thirty one male and female of a healthy subjects similar age range were control included in the group. The patients had been treated and registered for follow-up at the Clinic of Hematology of the University Hospital in Pleven. The diagnosis was made based on the International Working Group ( ) IWG -2009 criteria, in accordance with the methodological instructions part of the standard in that are s clinical hematology. The study d not include id individuals with diseases possibly affecting the levels of VNN1, i.e. inflammatory bowel disease, colorectal cancer and coronary heart disease ( ). I CHD nformed consent was obtained from each subject. The study was approved by the Ethics Committee at M U edical niversityPleven.
Biochemical Tests
Peripheral venous fasting blood samples, anticoagulated with EDTA w , ere collected from the tested subjects upon admission to hospital. The blood count standard test was carried out by methods. lasma s separated ithin 30 min P wa w after For this purpose blood withdrawal.
, the blood samples were centrifuged at 1000 g at 2-8°C for 15 min, after which the separated plasma wa before testing. s stored at 20°C -D e t e r m i n a t i o n o f H u m a n Pantetheinase (VNN1) in Plasma VNN1 levels in plasma were measured by ELISA kit (Cusabio Biotech Co., Ltd). amples were The s placed with a standard pipette onto microplates previously coated with a specific pantetheinaseantibody.
vailable b The pantetheinase a ound to the immobilized antibody. After removing the unbound substances, pantetheinase-specific biotin-conjugated antibody was added to the wells After washing, avidin conjugated to . horseradish peroxidase (HRP) was also added to the wells. the After washing and removal of unbound avidin substrate solution reagent was , a added The proportional .
coloration obtained was to the concentration bound pantetheinase, whose was measured by colorimetry.
D e t e r m i n a t i o n o f L i p i d Hydroperoxide in Plasma
The concentration of lipid hydroperoxides in the plasma was determined spectrophotometrically with Assay Kit Cayman 705002. The method is based on direct measurement of hydroperoxides through redox reaction with iron ions. Initially, ROOH extracted into chloroform, and thus is eliminates their ability to react with endogenous iron ions. Samples were assessed by spe tro at λ=490 nm using a 96-well c photometry , plate reader. 
Statistical Analysis
Results
Some basic and biochemical characteristics of the subjects studied are given in . ]. The purpose of this study was to find out if there exists a connection between available to easily determinable markers of oxidative stress and the clinical form of ITP in adults as defined according to modern classification of IWG -newly diagnosed, persistent and chronic ІTP.
We levels of plasma found increased pantet (VNN1) in newly diagnosed ITP heinase patients, as the compared with healthy controls. However, no changes were established between the groups of as patients and healthy individuals r e g a r d s t h e p l a s m a l e v e l s o f l i p i d hydroperoxide , marker of oxidative damage in s a circulation.
There is m , i ing that ultiple evidence ndicat o i xidative stress s a potential initiation mechanism of autoimmune diseases [2, 3, 5, 7, 8] However, results from few studies on the role . of P have been reported and oxidative stress in ІT some of the contradictory. levated se results are E levels of oxidative stress in patients with ІTP based on elevated levels of malondialdehyde, i n c r e a s e d t o t a l o x i d a n t s t a t u s a n d reduced oxidized glutathione / ratio have been reported [14] This study has some limitations. ITP is a rare disease and ly the groups studied were relative small. In the current classification of IWG newly , diagnosed ІT relatively P cases are presented as a heterogeneous group, only part of the can and m be classified as acute ІT . The study group P include adult comorbidity d patients, and might be expected to have an influence on the results, when comparing the study group and the control group.
Further studies with larger and more homogenous groups of patients and including more indicators of oxidative stress are needed to be able to draw statistically valid conclusions about the role and the possibility of using of oxidative biomarkers in diagnosing and treatment of ІTP.
